Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose

BACKGROUND: Reduced-antigen-content tetanus, diphtheria, and acellular pertussis (Tdap) vaccine is recommended in many countries for boosting immunity in adolescents and adults. Although immunity to these antigens wanes with time, currently available Tdap products are not labeled for repeat administ...

Descripción completa

Detalles Bibliográficos
Autores principales: Halperin, Scott A, Donovan, Catherine, Marshall, Gary S, Pool, Vitali, Decker, Michael D, Johnson, David R, Greenberg, David P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510947/
https://www.ncbi.nlm.nih.gov/pubmed/29438562
http://dx.doi.org/10.1093/jpids/pix113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510947/
https://www.ncbi.nlm.nih.gov/pubmed/29438562
http://dx.doi.org/10.1093/jpids/pix113

Ejemplares similares